• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Child-Turcotte-Pugh Score, MELD Score and MELD-Na Score as Predictors of Short-Term Mortality among Patients with End-Stage Liver Disease in Northern India.儿童-图尔科特-普格评分、终末期肝病模型(MELD)评分及MELD-钠评分作为印度北部终末期肝病患者短期死亡率的预测指标
Inflamm Intest Dis. 2020 Feb;5(1):1-10. doi: 10.1159/000503921. Epub 2019 Nov 8.
2
Predicting Mortality Across a Broad Spectrum of Liver Disease-An Assessment of Model for End-Stage Liver Disease (MELD), Child-Turcotte-Pugh (CTP), and Creatinine-Modified CTP Scores.预测广泛肝病患者的死亡率——对终末期肝病模型(MELD)、Child-Turcotte-Pugh(CTP)评分以及肌酐修正CTP评分的评估
J Clin Exp Hepatol. 2011 Dec;1(3):161-8. doi: 10.1016/S0973-6883(11)60233-8. Epub 2012 Jan 2.
3
[Comparative study of the MELD-Na and Child-Turcotte-Pugh scores as short-term prognostic indicators of acute-on-chronic hepatitis B liver failure].[MELD-Na评分与Child-Turcotte-Pugh评分作为慢性乙型肝炎急性肝衰竭短期预后指标的比较研究]
Zhonghua Gan Zang Bing Za Zhi. 2014 Nov;22(11):801-5. doi: 10.3760/cma.j.issn.1007-3418.2014.11.001.
4
Correlation of Model for End Stage Liver Disease (MELD), MELD-Sodium (MELD-Na), and Child-Turcotte-Pugh (CTP) Score With Frailty in Patients With Hepatitis C Virus (HCV) Related Cirrhosis.终末期肝病模型(MELD)、MELD-钠(MELD-Na)以及Child-Turcotte-Pugh(CTP)评分与丙型肝炎病毒(HCV)相关肝硬化患者虚弱程度的相关性
Cureus. 2023 Jun 17;15(6):e40574. doi: 10.7759/cureus.40574. eCollection 2023 Jun.
5
The Utility of the Platelet-Albumin-Bilirubin Score as a Non-invasive Predictor of Esophageal Varices and Variceal Hemorrhage in Patients With Liver Cirrhosis Compared to Child-Turcotte-Pugh and Model of End-Stage Liver Disease-Sodium Scores.与Child-Turcotte-Pugh评分和终末期肝病-钠评分相比,血小板-白蛋白-胆红素评分作为肝硬化患者食管静脉曲张和静脉曲张出血的无创预测指标的效用。
Cureus. 2024 Jun 18;16(6):e62577. doi: 10.7759/cureus.62577. eCollection 2024 Jun.
6
[Comparison of CTP, MELD, and MELD-Na scores for predicting short term mortality in patients with liver cirrhosis].[比较CTP、MELD和MELD-Na评分对预测肝硬化患者短期死亡率的价值]
Korean J Gastroenterol. 2007 Aug;50(2):92-100.
7
Creatinine-modified Child-Turcotte-Pugh score is a good predictor of a short-term survival in patients with bleeding from esophageal varices.肌酐校正的Child-Turcotte-Pugh评分是食管静脉曲张出血患者短期生存的良好预测指标。
Vojnosanit Pregl. 2017 Jan;74(1):13-8. doi: 10.2298/VSP150717147R.
8
Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients?纳入血清肌酐值能否改善Child-Turcotte-Pugh评分,并在肝硬化患者的短期预后评估中对终末期肝病模型评分的预后价值提出挑战?
Liver Int. 2004 Oct;24(5):465-70. doi: 10.1111/j.1478-3231.2004.0949.x.
9
Comparison of the ability of the PDD-ICG clearance test, CTP, MELD, and MELD-Na to predict short-term and medium-term mortality in patients with decompensated hepatitis B cirrhosis.比较PDD-吲哚菁绿清除试验、CTP、MELD和MELD-Na预测失代偿期乙型肝炎肝硬化患者短期和中期死亡率的能力。
Eur J Gastroenterol Hepatol. 2016 Apr;28(4):444-8. doi: 10.1097/MEG.0000000000000538.
10
Integrated model for end-stage liver disease maybe superior to some other model for end-stage liver disease-based systems in addition to Child-Turcotte-Pugh and albumin-bilirubin scores in patients with hepatitis B virus-related liver cirrhosis and spontaneous bacterial peritonitis.终末期肝病模型或许优于其他基于终末期肝病模型的系统,包括 Child-Turcotte-Pugh 评分和白蛋白-胆红素评分,在乙型肝炎病毒相关性肝硬化和自发性细菌性腹膜炎患者中。
Eur J Gastroenterol Hepatol. 2019 Oct;31(10):1256-1263. doi: 10.1097/MEG.0000000000001481.

引用本文的文献

1
Vitamin D Deficiency and Chronic Liver Disease: Investigating Predictive Factors and Their Implications for Patient Care in Pakistan.维生素D缺乏与慢性肝病:探究巴基斯坦的预测因素及其对患者护理的影响。
Iran J Public Health. 2025 May;54(5):1054-1063. doi: 10.18502/ijph.v54i5.18640.
2
Sarcopenia and Frailty in Cirrhotic Patients: Evaluation of Prevalence and Risk Factors in a Single-Centre Cohort Study.肝硬化患者的肌肉减少症和衰弱:单中心队列研究中患病率及危险因素的评估
Medicina (Kaunas). 2025 Apr 29;61(5):821. doi: 10.3390/medicina61050821.
3
A nomogram model based on albumin-bilirubin score for predicting 90-day prognosis in patients with acute-on-chronic liver failure.一种基于白蛋白-胆红素评分的列线图模型,用于预测慢性肝衰竭急性发作患者的90天预后。
Front Med (Lausanne). 2025 Jan 6;11:1406275. doi: 10.3389/fmed.2024.1406275. eCollection 2024.
4
A Novel Scoring System for Assessing In-Hospital Mortality Risk in Patients With Liver Cirrhosis.一种用于评估肝硬化患者院内死亡风险的新型评分系统。
Cureus. 2024 Nov 1;16(11):e72823. doi: 10.7759/cureus.72823. eCollection 2024 Nov.
5
Real-world analysis on the use of gamma-hydroxybutyric acid for alcohol withdrawal syndrome in hospitalized patients with diagnosis of cirrhosis.对诊断为肝硬化的住院患者使用γ-羟基丁酸治疗酒精戒断综合征的真实世界分析。
Intern Emerg Med. 2025 Jan;20(1):119-129. doi: 10.1007/s11739-024-03761-x. Epub 2024 Sep 9.
6
Establishment of a prognostic model for hospitalized cirrhotic patients with infection based on lumbar muscle mass.基于腰大肌质量建立住院感染性肝硬化患者的预后模型
Heliyon. 2024 Feb 8;10(4):e25739. doi: 10.1016/j.heliyon.2024.e25739. eCollection 2024 Feb 29.
7
The efficacy and safety of granulocyte colony-stimulating factor in the treatment of acute-on-chronic liver failure: A systematic review and meta-analysis.粒细胞集落刺激因子治疗慢加急性肝衰竭的疗效和安全性的系统评价和荟萃分析。
PLoS One. 2023 Nov 30;18(11):e0294818. doi: 10.1371/journal.pone.0294818. eCollection 2023.
8
Utility of Subjective Global Nutritional Assessment Tool for the Assessment of Malnutrition in Pediatric Patients with Chronic Liver Disease.主观全面营养评估工具在评估慢性肝病患儿营养不良中的应用价值。
Pediatr Gastroenterol Hepatol Nutr. 2023 Nov;26(6):346-354. doi: 10.5223/pghn.2023.26.6.346. Epub 2023 Oct 30.
9
Model for End Stage Liver Disease (MELD) Score: A Tool for Prognosis and Prediction of Mortality in Patients With Decompensated Liver Cirrhosis.终末期肝病模型(MELD)评分:一种用于失代偿期肝硬化患者预后及死亡预测的工具。
Cureus. 2023 May 20;15(5):e39267. doi: 10.7759/cureus.39267. eCollection 2023 May.
10
Determining Prognosis of ALD and Alcohol-associated Hepatitis.确定酒精性肝病(ALD)和酒精性肝炎的预后
J Clin Exp Hepatol. 2023 May-Jun;13(3):479-488. doi: 10.1016/j.jceh.2022.10.010. Epub 2022 Nov 3.

本文引用的文献

1
Etiology and mode of presentation of chronic liver diseases in India: A multi centric study.印度慢性肝病的病因及临床表现:一项多中心研究。
PLoS One. 2017 Oct 26;12(10):e0187033. doi: 10.1371/journal.pone.0187033. eCollection 2017.
2
Performance of scoring systems to predict mortality of patients with acute-on-chronic liver failure: A systematic review and meta-analysis.预测慢加急性肝衰竭患者死亡率的评分系统性能:一项系统评价和荟萃分析。
J Gastroenterol Hepatol. 2017 Oct;32(10):1668-1678. doi: 10.1111/jgh.13786.
3
Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data.美国非酒精性脂肪性肝炎相关肝硬化的患病率:基于国家健康与营养检查调查数据的分析
Am J Gastroenterol. 2017 Apr;112(4):581-587. doi: 10.1038/ajg.2017.5. Epub 2017 Feb 14.
4
Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology.意大利肝硬化的特征:丙型肝炎病毒病因学作用减弱的证据。
Eur J Intern Med. 2017 Mar;38:68-72. doi: 10.1016/j.ejim.2016.10.012. Epub 2016 Nov 9.
5
Hyponatremia and Hepatorenal Syndrome.低钠血症与肝肾综合征
Gastroenterol Hepatol (N Y). 2015 Apr;11(4):220-9.
6
The Metabolic Syndrome and Its Influence on Nonalcoholic Steatohepatitis.代谢综合征及其对非酒精性脂肪性肝炎的影响。
Clin Liver Dis. 2016 May;20(2):225-43. doi: 10.1016/j.cld.2015.10.002. Epub 2015 Dec 14.
7
Child-Pugh Versus MELD Score for the Assessment of Prognosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis of Observational Studies.用于评估肝硬化预后的Child-Pugh评分与终末期肝病模型(MELD)评分:观察性研究的系统评价和荟萃分析
Medicine (Baltimore). 2016 Feb;95(8):e2877. doi: 10.1097/MD.0000000000002877.
8
Changing prioritization for transplantation: MELD-Na, hepatocellular carcinoma exceptions, and more.改变移植的优先排序:终末期肝病模型-钠评分、肝细胞癌例外情况等等。
Curr Opin Organ Transplant. 2016 Apr;21(2):120-6. doi: 10.1097/MOT.0000000000000281.
9
Retrospective evaluation of prognostic score performances in cirrhotic patients admitted to an intermediate care unit.对入住中级护理病房的肝硬化患者预后评分表现的回顾性评估。
Dig Liver Dis. 2015 Aug;47(8):675-81. doi: 10.1016/j.dld.2015.04.001. Epub 2015 Apr 13.
10
Hyponatremia in cirrhosis: pathophysiology and management.肝硬化中的低钠血症:病理生理学与管理
World J Gastroenterol. 2015 Mar 21;21(11):3197-205. doi: 10.3748/wjg.v21.i11.3197.

儿童-图尔科特-普格评分、终末期肝病模型(MELD)评分及MELD-钠评分作为印度北部终末期肝病患者短期死亡率的预测指标

Child-Turcotte-Pugh Score, MELD Score and MELD-Na Score as Predictors of Short-Term Mortality among Patients with End-Stage Liver Disease in Northern India.

作者信息

Acharya Gagandeep, Kaushik Rajeev Mohan, Gupta Rohit, Kaushik Reshma

机构信息

Department of General Medicine, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Dehradun, India.

出版信息

Inflamm Intest Dis. 2020 Feb;5(1):1-10. doi: 10.1159/000503921. Epub 2019 Nov 8.

DOI:10.1159/000503921
PMID:32232049
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7098314/
Abstract

BACKGROUND AND OBJECTIVES

Child-Turcotte-Pugh (CTP), Model for End-Stage Liver Disease (MELD) and MELD-sodium (MELD-Na) scores are used for predicting disease severity and mortality among patients with end-stage liver disease. However, data regarding their usefulness in predicting the short-term outcome of end-stage liver disease are not available in India. This prospective study compared the CTP score, MELD score and MELD-Na score as predictors of short-term outcome among patients with end-stage liver disease.

METHODS

CTP, MELD and MELD-Na scores were determined in 171 patients with end-stage liver disease at a tertiary healthcare centre in India at the time of admission, and the concordance (C-) statistics of the three scores for 3-month mortality were assessed and compared. The aetiology of end-stage liver disease and the clinical presentation were determined.

RESULTS

The CTP score, MELD score and MELD-Na score on day 1 were significantly higher among non-survivors than among survivors ( < 0.0001 each). The C-statistic for 3-month mortality for the CTP score was 0.93 ( < 0.0001), that for the MELD score was 0.86 ( < 0.0001) and that for the MELD-Na score was 0.83 ( < 0.0001). The C-statistics of these scores differed significantly for 3-month mortality, and the CTP score was better than the MELD ( < 0.0001) and MELD-Na ( < 0.0001) scores in predicting 3-month mortality.

CONCLUSIONS

The CTP, MELD and MELD-Na scores were very good predictors of mortality at 3 months among patients with end-stage liver disease. The CTP score was superior to the MELD and MELD-Na scores in predicting 3-month mortality.

摘要

背景与目的

儿童-托考特-普格(CTP)评分、终末期肝病模型(MELD)评分和MELD-钠(MELD-Na)评分用于预测终末期肝病患者的疾病严重程度和死亡率。然而,在印度,关于它们在预测终末期肝病短期预后方面有用性的数据尚不可得。这项前瞻性研究比较了CTP评分、MELD评分和MELD-Na评分作为终末期肝病患者短期预后的预测指标。

方法

在印度一家三级医疗中心,对171例终末期肝病患者入院时测定CTP、MELD和MELD-Na评分,并评估和比较这三个评分对3个月死亡率的一致性(C-)统计量。确定终末期肝病的病因和临床表现。

结果

非幸存者第1天的CTP评分、MELD评分和MELD-Na评分显著高于幸存者(均P<0.0001)。CTP评分对3个月死亡率的C统计量为0.93(P<0.0001),MELD评分为0.86(P<0.0001),MELD-Na评分为0.83(P<0.0001)。这些评分对3个月死亡率的C统计量有显著差异,CTP评分在预测3个月死亡率方面优于MELD评分(P<0.0001)和MELD-Na评分(P<0.0001)。

结论

CTP、MELD和MELD-Na评分是终末期肝病患者3个月死亡率的良好预测指标。CTP评分在预测3个月死亡率方面优于MELD评分和MELD-Na评分。